TIAA CREF Investment Management’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-136,290
Closed -$1.15M 3142
2015
Q4
$1.15M Sell
136,290
-33,461
-20% -$224K ﹤0.01% 2499
2015
Q3
$710K Buy
169,751
+30,870
+22% +$135K ﹤0.01% 2762
2015
Q2
$732K Buy
+138,881
New +$890K ﹤0.01% 2842

TIAA CREF Investment Management's OCAT Position: Q1 2016 in Review

TIAA CREF Investment Management sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 136,290 shares — an estimated $1.15M sold.

TIAA CREF Investment Management first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $1.15M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • TIAA CREF Investment Management reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • TIAA CREF Investment Management sold 136,290 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $1.15M.
  • TIAA CREF Investment Management first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • TIAA CREF Investment Management's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $1.15M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on TIAA CREF Investment Management's 13F filing for Q1 2016, filed 6 May 2016.